Butler John P.
SEC CIK 1591467 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | CEO, Pres, Dir | 3.72M | $86.6K | $1.35M | 18 | 2018-12-12 | 2026-08-06 |
Most active insiders at AKBA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Butler John P. | CEO, Pres, Dir | $86.6K | $474.4K |
| 2 | Grund Nicholas | Chief Commercial Off | — | $117.9K |
| 3 | Ostrowski Erik | SVP, CFO, CBO, Treas | — | $110.8K |
| 4 | Rucci Carolyn M. | SVP, CLO | — | $97.0K |
| 5 | Burke Steven Keith | SVP, Chief Medical Off | — | $94.0K |
| 6 | Malabre Richard C | SVP, CAO | — | $68.8K |
| 7 | FRIESON RON | Dir | — | — |
| 8 | Wolf Myles | Dir | — | — |
| 9 | Smith Cynthia | Dir | — | — |
| 10 | ADAMS ADRIAN | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 16:08 | 2026-08-06 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | M - OptEx | $0.63 | +350.0K | 3.72M | +10% | +$220.5K |
| 2026-03-05 | 2026-03-04 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | P - Purchase | $1.25 | +69.3K | 3.37M | +2% | +$86.6K | |
| T | 2026-02-04 | 2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | A - Grant | $1.41 | +175.2K | 3.38M | +5% | +$247.1K |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $1.39 | -341.3K | 3.42M | -9% | -$474.4K |
| D | 2026-02-03 | 2026-01-30 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +743.0K | 3.46M | +27% | $0 |
| T | 2025-03-04 | 2025-03-03 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $1.83 | -46.4K | 2.56M | -2% | -$84.9K |
| DMT | 2025-02-04 | 2025-02-03 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $2.10 | -144.2K | 2.60M | -5% | -$302.9K |
| DT | 2025-02-04 | 2025-01-31 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +701.0K | 2.75M | +34% | $0 |
| 2024-03-01 | 2024-02-29 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $1.58 | -46.6K | 2.04M | -2% | -$73.6K | |
| 2024-02-29 | 2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $1.52 | -37.7K | 2.09M | -2% | -$57.4K | |
| D | 2024-02-02 | 2024-02-01 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $1.68 | -46.5K | 2.13M | -2% | -$78.1K |
| D | 2024-02-02 | 2024-01-31 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +603.5K | 2.18M | +38% | $0 |
| M | 2023-03-03 | 2023-03-01 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $0.88 | -91.9K | 1.57M | -6% | -$80.8K |
| 2023-03-01 | 2023-02-27 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $0.81 | -38.6K | 1.66M | -2% | -$31.3K | |
| D | 2023-02-02 | 2023-01-31 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +293.1K | 1.70M | +21% | $0 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | A - Grant | $0.00 | +293.1K | 1.46M | +25% | $0 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | S - Sale | $2.16 | -79.0K | 1.43M | -5% | -$171.0K |
| A | 2022-02-18 | 2018-12-12 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres, Dir | J - Other | — | +1,248 | 375.9K | +0.3% | — |
Purchase Sale Sale after option exercise All abbreviations